Jerrold R. Turner
Affiliations: | Pathology | University of Chicago, Chicago, IL |
Area:
Molecular Biology, Biomechanics BiophysicsGoogle:
"Jerrold Turner"Children
Sign in to add trainee| Le Shen | grad student | 2005 | Chicago |
| Daniel Clayburgh | grad student | 2006 | Chicago |
| W. V. Graham | grad student | 2010 | Chicago |
| Amanda M. Marchiando | grad student | 2010 | Chicago |
| David R. Raleigh | grad student | 2010 | Chicago |
| Dan Yu | grad student | 2010 | Chicago |
| Samuel C. Nalle | grad student | 2011 | Chicago |
| Ekaterina A. Khramtsova | grad student | 2014 | Chicago |
| Pawin Pongkorpsakol | post-doc | 2018-2020 | Harvard Medical School - Brigham and Women's Hospital (Physiology Academic Tree) |
Collaborators
Sign in to add collaborator| Muriel Darnaudery | collaborator | 2018-2022 | McLean | Hospital Harvard Medical School (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chanez-Paredes SD, Abtahi S, Zha J, et al. (2024) Mechanisms underlying distinct subcellular localizations and regulation of epithelial long myosin light chain kinase (MLCK) splice variants. The Journal of Biological Chemistry. 105643 |
| Kaak JL, Lobo de Sá FD, Turner JR, et al. (2022) Unraveling the intestinal epithelial barrier in cyanotoxin microcystin-treated Caco-2 cell monolayers. Annals of the New York Academy of Sciences |
| Zuo L, Kuo WT, Cao F, et al. (2022) Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn's disease. Gut |
| Shashikanth N, Rizzo HE, Pongkorpsakol P, et al. (2021) Correction: Electrophysiologic Analysis of Tight Junction Size and Charge Selectivity. Current Protocols. 1: e259 |
| Shashikanth N, Rizzo HE, Pongkorpsakol P, et al. (2021) Electrophysiologic Analysis of Tight Junction Size and Charge Selectivity. Current Protocols. 1: e143 |
| Pongkorpsakol P, Turner JR, Zuo L. (2020) Culture of Intestinal Epithelial Cell Monolayers and Their Use in Multiplex Macromolecular Permeability Assays for In Vitro Analysis of Tight Junction Size Selectivity. Current Protocols in Immunology. 131: e112 |
| Cao F, Zhu L, Zhang J, et al. (2020) Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 131: 110665 |
| Labarta-Bajo L, Nilsen SP, Humphrey G, et al. (2020) Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection. The Journal of Experimental Medicine. 217 |
| Pai YC, Weng LT, Wei SC, et al. (2020) Gut microbial transcytosis induced by tumor necrosis factor-like 1A-dependent activation of a myosin light chain kinase splice variant contributes to IBD. Journal of Crohn's & Colitis |
| Kang JW, Yan J, Ranjan K, et al. (2020) Myeloid Cell Expression of LACC1 is Required for Bacterial Clearance and Control of Intestinal Inflammation. Gastroenterology |